Prenetics Global Ltd — Form F-1/A
Filed September 22, 2026 · analyzed by the Registration Agent
F-1/A
— Neutral
significance 8/100
What the filing says
Prenetics Global Limited filed Pre-effective Amendment No. 3 to its Form F-1 registration statement on September 22, 2026, solely to add consents from KPMG (Exhibit 23.2) and Deloitte Touche Tohmatsu (Exhibits 23.3 and 23.4). The amendment contains no substantive changes to the registration statement itself. The consents relate to KPMG's audit report dated April 30, 2024 (as updated April 30, 2026 for discontinued operations of ACT Genomics) and Deloitte's reports on consolidated financials for FY2025 and subsidiary Insighta's financials for 2024–2025.
Why this rating
Routine procedural amendment adding required auditor consents for SEC registration; no material business, financial, or operational changes disclosed.
See more from September 22, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.